Work

Clinical experience of a targeted TCR-IL2 fusion protein in combination with cisplatin (CDDP) in patients (pts) with metastatic melanoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.e13088

Authors: Mohammed M. Milhem, Jeffrey S. Weber, Asim Amin, Sanjiv S Agarwala, David H. Lawson, John A. Thompson, Steven O'Day, Gregory K. Pennock, Jon M. Richards, Timothy Kuzel, Liza Hernandez, Bee-Yau Huang, Peter Rhode, Hing C. Wong

Institutions: University of Iowa, University of Iowa Hospitals and Clinics, Moffitt Cancer Center, Carolinas Medical Center, St. Luke's Hospital, Emory University, Seattle Cancer Care Alliance, Angeles Clinic and Research Institute, The University of Texas MD Anderson Cancer Center, Oncology Specialists, Northwestern University, Altor BioScience (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599048108

Cites:

Cited by: 4

Related to: 10